A Rare Side Effect of Entecavir: Hepatomegaly and Steatosis
Journal Title: Viral Hepatitis Journal - Year 2017, Vol 23, Issue 3
Abstract
Hepatomegaly and steatosis are rare but potentially fatal side-effects of nucleoside analogues. Here, we present the case of development of hepatomegaly and steatosis in a 53-year-old male who had been treated with entecavir for five years. There were no symptoms of lactic acidosis. At three months after changing entecavir to tenofovir, the liver size returned to normal and maintained within the normal range during the 3-year follow-up. Therefore, it can be presumed that the hepatomegaly and steatosis were due to entecavir therapy. There are very few reports of hepatomegaly and steatosis caused by nucleoside analogues and the majority of the reported cases were associated with lactic acidosis. To the best of our knowledge, there are no previously reported cases of hepatomegaly and steatosis due to entecavir therapy without evidence of lactic acidosis. The aim of this clinical report was to point out a rare side-effect of entecavir and to share our treatment approach.
Authors and Affiliations
Tayibe BAL, Yusuf ÖNLEN, Selma İLKAY ŞAHİN
Keywords
Related Articles
- EP ID EP268764
- DOI 10.4274/vhd.0012
- Views 79
- Downloads 0
Molecular Characterization of Hepatitis B Virus Strains Isolated from Chronic Hepatitis B Patients in Southeastern Region of Turkey
Objectives: The aim of the present study was to assess the molecular aspects of HBV strains isolated from chronic hepatitis B (CHB) patients, in the Southeastern region of Turkey. Materials and Methods: The study involve...
Two Rare Causes of Hepatitis: Fascioliasis and Brucellosis
Brucellosis and fascioliasis are zoonoses which induce different type of cell-mediated immune responses and rarely cause hepatitis with together. Brucellosis induces T helper type 1 (Th1) immune response whereas Fasciola...
Current Treatment Approach in Acute Hepatitis C Infection
Acute hepatitis C virus (HCV) infection has an asymptomatic course in most patients. There is no sufficient data regarding its epidemiological features. Recent advances in the treatment of chronic HCV infection have led...
A Case of Hepatitis B Reactivation with Acute Flare Three Months After Tenofovir Prophylaxis Withdrawal in a Allogenic Hematopoietic Stem Cell Transplantation Patient
Hepatitis B virus (HBV) infection is a major health problem worldwide. HBV reactivation is associated with high mortality rates in hematopoietic stem cell transplantation (HSCT) and, prophylactic antiviral treatment is s...
Hepatitis B Virus Vaccination Rates among Medical Laboratory Workers: A Multi-centered Assessment
Objective: In this multicenter study, we aimed to determine the rates of hepatitis B virus (HBV) in medical laboratory workers in Turkey and to discuss the current status. Materials and Methods: We designed this study as...